Semaglutide 8mg

ઉત્પાદન વર્ણન

Semaglutide 8 mg

Product Overview:
Semaglutide 8 mg is an advanced GLP-1 receptor agonist designed for the management of type 2 diabetes and obesity. This high-potency formulation aids in glycemic control and promotes weight reduction by enhancing insulin secretion, slowing gastric emptying, and suppressing appetite.

Key Benefits:

• Effective Glycemic Control: Improves blood sugar levels in adults with type 2 diabetes.
• Weight Reduction: Facilitates sustainable weight loss as part of a comprehensive treatment plan.
• Convenient Once-Weekly Dosing: Simplifies administration and improves patient adherence.
• Proven Efficacy: Backed by clinical trials demonstrating significant results.

Composition:

• Active Ingredient: Semaglutide 8 mg per pen
• Excipients: Pharmaceutical-grade stabilizers and solvents

Indications:

• Management of type 2 diabetes mellitus in adults
• Weight management in adults with a BMI ‰30 or ‰27 with related comorbidities

Dosage and Administration:
Semaglutide 8 mg is administered via subcutaneous injection once weekly. Follow the dosage and instructions as prescribed by a healthcare professional.

Storage Instructions:

• Store at 2“8C (refrigerated). Avoid freezing.
• Protect from light and moisture. Keep out of reach of children.

Precautions:

• Use under medical supervision only.
• Not recommended for individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
• Inform your healthcare provider about any medications or health conditions before starting treatment.

Disclaimer:
This product is for export and professional use only. Always consult a healthcare professional before use.

This detailed description outlines the features, benefits, and usage instructions for Semaglutide 8 mg, maintaining clarity and professionalism.